PET imaging on cardiology

Hellenic Journal of Nuclear Medicine

Volumn 8, Issue 3, 2005, Pages 140-144

  Chacko, George N ^a  

^a Midwest Medical Isotopes   (United States)

Author keywords

Hibernating myocardium; PET camera cardiology; PET camera design; PET camera principles; Stunning myocardium

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; RUBIDIUM 82;

CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CYCLOTRON; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EQUIPMENT DESIGN; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; INCIDENCE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTION; REVIEW; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOLOGY; EQUIPMENT DESIGN; FLUORODEOXYGLUCOSE F18; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 30344442423     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Mullani NA, Gould KA. First pass regional blood flow measurements with external detectors. J Nucl Med 1983; 24: 577-581.
2. Hoffman EJ, Phelps ME. Positron Emission Tomography: Principles and Quantitation: Applications for the Brain and Heart. New York Raven Press 1986, 237-286.
3. Casey ME, Nutt R. A multicrystal two dimensional BGO detector system for PET IEEE. Trans Nucl Sci 1986; 33: 460-463.
4. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379.
5. Hobbs FDR, Jones MI, Allan TF, et al. European survey of primary care physician perceptions on heart failure diagnosis and management. Eur Heart J 2000; 2: 423-429.
6. Johansson S, Wallander MA, Rodriguez AG. Incidence of newly diagnosed heart failure in UK general practice. Eur J Heart Failure 2001; 3: 225-231.
7. Mullani NA, Goldstein RA, Gould KL. Myocardial perfusion with Rubidium-82. I Measurement of extraction fraction with external detectors. J Nucl Med 1983; 24: 898-906.
8. Goldstein RA, Mullani NA, Gould KA, et al. Myocardial perfusion with Rubidium 82. II The effect of metabolic and pharmacologic interventions. J Nucl Med 1983; 24 907-915.
9. Schelbert HR, Phelps ME, Hoffman EJ, et al., N-13 Ammonia as an indicator of myocardial blood flow. Circulation 1981; 63; 1258-1272.
10. Senni M, Tribouilloy CM. Congestive heart failure in the community: a study of all incident cases in Olmsted County MN in 1991. Circulation 1989; 98: 2282-2289.
11. Leppo J, Plaja J, Gionet, et al. Non-invasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiology 1987; 9: 269-276.
12. National Heart Lung and Blood Institute Morbidity and Mortality chartbook on cardiovascular, lung and blood diseases, NIH, Bethesda, MD 1998.
13. Mock MB, Ringqvist I, Fisher ID. Survival of medically treated patients in coronary artery surgery study (CASS) registry. Circulation 1982; 66: 562-568.
14. Alderman EL, Fisher ID, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-795.
15. Schelbert HR, Phelps ME, Hoffman EJ, et al. Regional myocardial perfusion assessed with N-13 Ammonia and PET. Am J Cardiology 1979; 43: 209-218.
16. Yoshida K, Endo M. Measurement of regional myocardial blood flow in hypertrophic cardiomyopathy: Application of the first pass flow model using N-13 Ammonia and PET. Am J Physio Imaging 1987; 4: 97-104.
17. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole Thallium-201 for evaluation of ischemic heart disease. J Am Coll Cardiology 1990; 65: 109-116.
18. Depre C, Vanoverschelde JJ. Chronic myocardial hibernation in humans from bedside to bench. Circulation 1997; 95: 1961-1971.
19. Borger M, Ausma J. Structural aspects of chronic hibernating myocardium in man. Basic Res Cardiology 1995; 90: 44-46.
20. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
21. Braunwald E, Kloner RA. The stunned myocardium, prolonged, post-ischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149.
22. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia in man with PET using F-18 deoxyglucose (FDG) and N-13 Ammonia. Circulation 1983; 67: 766-788.
23. Maes A, Flameng Nuyts J, Histological altercations in chronically hypoperfused myocardium. Circulation 1994; 90: 735-745.
24. Kitsiou AN, Bacharach SL, Bartlett, et al. N-13 Ammonia myocardial blood flow and FDG uptake, relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 1992; 29: 559-565.
25. Vanoverschelde JJ, Melin JA, Depre C, et al. Time course of functional recovery of hibernating myocardium after coronary revascularization (abstr). Circulation 1994; 90: 378.
26. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of Technetium-99m hexais 2-methoxyisobutylisonitrile SPECT and F-18 deoxyglucose (FDG) PET in patients with coronary artery disease. Eur J Nucl Med 1992; 19874-19881.
27. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging PET in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiology 1994; 73: 527-533.
28. Lee KS, Marwich, Cook SA, et al. Prognosis of patients with left ventricular dysfunction with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2687-2694.
29. Baumgartner H, Porenta G, Yuk-Kong, et al. assessment of myocardial viability with dobutamine echocardiography, PET and Thallium-201 SPECT: Correlation with histopathology in explanted hearts. J Am Coll Cardiology 1998; 32: 1701-1708.